Page last updated: 2024-08-22

vidarabine and Hypotension

vidarabine has been researched along with Hypotension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byrd, JC; Gockerman, J; Hohl, R; Hurd, D; Larson, RA; Nattam, S; Perry, MC; Peterson, BL; Rai, KR1
Imamura, T; Kadota, J; Kikuchi, H; Kohno, K; Ogata, M; Ohtsuka, E; Tomo, T1

Trials

1 trial(s) available for vidarabine and Hypotension

ArticleYear
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:10

    Topics: Adult; Aged; Alemtuzumab; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Bone Marrow Diseases; CD52 Antigen; Cohort Studies; Cytomegalovirus Infections; Feasibility Studies; Female; Glycoproteins; Humans; Hypotension; Infusions, Intravenous; Injections, Subcutaneous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Proteins; Survival Analysis; Vidarabine

2009

Other Studies

1 other study(ies) available for vidarabine and Hypotension

ArticleYear
Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis.
    American journal of hematology, 2006, Volume: 81, Issue:4

    Topics: Adult; Amyloidosis; Diarrhea; Drug Therapy, Combination; Heart Diseases; Humans; Hypotension; Japan; Kidney Diseases; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2006